A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

JANET D. ROWLEY

doi:10.1038/243290a0

journal article Jun 01, 1973

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

JANET D. ROWLEY

Nature Vol. 243 No. 5405 pp. 290-293 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/243290a0

Topics

No keywords indexed for this article. Browse by subject →

References

16

[1]

Chicago Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1966).

[2]

Paris Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1972).

[3]

Rowley, J. D., Blaisdell, R. K., and Jacobson, L. O., Blood, 27, 782 (1966). 10.1182/blood.v27.6.782.782

[4]

Rowley, J. D., Potter, D., and Mikuta, J., Stain Tech., 46, 97 (1971).

[5]

Pearson, P. L., Bobrow, M., and Vosa, C. G., Nature, 226, 78 (1970). 10.1038/226078a0

[6]

Sumner, A. T., Evans, H. J., and Buckland, R. A., Nature New Biology, 232, 31 (1971). 10.1038/newbio232031a0

[7]

Rowley, J. D., and Bodmer, W. F., Nature, 231, 503 (1971). 10.1038/231503a0

[8]

Caspersson, T., Gahrton, G., Lindsten, J., and Zech, L., Exp. Cell Res., 63, 238 (1970). 10.1016/0014-4827(70)90362-9

[9]

O'Riordan, M. L., Robinson, J. A., Buckton, K. E., and Evans, H. J., Nature, 230, 167 (1971). 10.1038/230167a0

[10]

Rudkin, G. T., and Hungerford, D. A., Science, NY, 144, 1229 (1964). 10.1126/science.144.3623.1229

[11]

Whang-Peng, J., Canellos, G. P., Carbone, P. P., and Tjio, J. H., Blood, 32, 755 (1968). 10.1182/blood.v32.5.755.755

[12]

Ezdinli, E. Z., Sokal, J. E., Crosswhite, B. S., and Sandberg, A. A., Ann. Int. Med., 72, 175 (1970). 10.7326/0003-4819-72-2-175

[13]

Lobb, D. S., Reeves, B. R., and Lawler, S. D., Lancet, i 849 (1972). 10.1016/s0140-6736(72)90836-7

[14]

Rowley, J. D., Ann. Génét. (in the press).

[15]

Manolov, G., and Manolova, Y., Hereditas, 69, 300 (1971).

[16]

Mark, J., Levan, G., and Mitelman, F., Hereditas, 71, 163 (1972). 10.1111/j.1601-5223.1972.tb01017.x

Cited By

3,302

Clonal hematopoiesis of indeterminate potential and atrial fibrillation

Jie Liu, Nan Zhang · 2026

Heart Rhythm

First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan

Shezad Yousif Edo, Zeki Ali Mohammed · 2025

Iraqi Journal of Hematology

BCR-ABL: The molecular mastermind behind chronic myeloid leukemia

Tara Shammas, Malalage N. Peiris · 2025

Cytokine & Growth Factor Review...

Oncogenic gene fusions in cancer: from biology to therapy

Stephen V. Liu, Misako Nagasaka · 2025

Signal Transduction and Targeted Th...

Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity

Haruki Ujiie, Tomoko Sakyo · 2025

Cancer Medicine

The reckoning of chromosomal instability: past, present, future

Andrew Lynch, Shermineh Bradford · 2024

Chromosome Research

Application of modified gold nanoparticles to improve characteristics of DNA hybridization biosensor based on surface plasmon resonance spectrometry

M. S. Sobolevskyi, O. O. Soldatkin · 2023

Applied Nanoscience

Computational immunogenomic approaches to predict response to cancer immunotherapies

Venkateswar Addala, Felicity Newell · 2023

Nature Reviews Clinical Oncology

Targeting BCR-ABL1-positive leukaemias: a review article

Steven Leak, Gillian A. Horne · 2023

Cambridge Prisms: Precision Medicin...

P‐Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients

Bushra Kaleem, Sadaf Shahab · 2022

International Journal of Laboratory...

Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation

Haixia Liu, Xinyu Ding · 2021

European Journal of Medicinal Chemi...

Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations

Anu R. Melge, Lekshmi G. Kumar · 2019

Journal of Biomolecular Structure a...

Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease

Siddhartha Jaiswal, Peter Libby · 2019

Nature Reviews Cardiology

Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells

Marta D. Kolba, Wioleta Dudka · 2019

Cell Death & Disease

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

Andreas Hochhaus, Franҫois-Xavier Mahon · 2017

Journal of Cancer Research and Clin...

Synthesis and identification of GZD856 as an orally bioavailable Bcr-AblT315I inhibitor overcoming acquired imatinib resistance

Xiaoyun Lu, Zhang Zhang · 2017

Journal of Enzyme Inhibition and Me...

Apoptosis and Cancer

Anthony Letai · 2017

Annual Review of Cancer Biology

SPR Detection and Discrimination of the Oligonucleotides Related to the Normal and the Hybrid bcr-abl Genes by Two Stringency Control Strategies

M. J. Matsishin, Iu. V. Ushenin · 2016

Nanoscale Research Letters

BMI1: A Biomarker of Hematologic Malignancies

Anagh A. Sahasrabuddhe · 2016

Biomarkers in Cancer

The spectrum of adaptive mutations in experimental evolution

Gregory I. Lang, Michael M. Desai · 2014

Genomics

Metrics

3,302

Citations

16

References

Details

Published: Jun 01, 1973
Vol/Issue: 243(5405)
Pages: 290-293
License: View

Authors

J

JANET D. ROWLEY

Cite This Article

JANET D. ROWLEY (1973). A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining. Nature, 243(5405), 290-293. https://doi.org/10.1038/243290a0

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

You May Also Like